Meta-analysis: Anti-viral therapy of hepatitis B virus-associated glomerulonephritis

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 5, 2006, Pages 781-788

  Fabrizi, F ^a   Dixit, V ^b   Martin, P ^c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; RECOMBINANT ALPHA2B INTERFERON;

ANTIGEN DETECTION; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GLOMERULONEPHRITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS ASSOCIATED GLOMERULONEPHRITIS; HUMAN; META ANALYSIS; MORBIDITY; MYALGIA; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; REGRESSION ANALYSIS; REMISSION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; FEMALE; GLOMERULONEPHRITIS; HEPATITIS B ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERONS; LAMIVUDINE; MALE; NEPHROTIC SYNDROME; PATIENT DROPOUTS; TREATMENT OUTCOME;

EID: 33747338651     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03041.x     Document Type: Article

References (43)

1. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004; 24: 198-211.
2. Johnson RJ, Couser W. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990; 37: 663-76.
3. Lee HS, Choi Y, Yu SH, Koh HI, Kim MJ, Ko KW. A renal biopsy study of hepatitis B virus-associated nephropathy in Korea. Kidney Int 1988; 34: 537-43.
4. Hattori S, Furuse A, Matsuda I. Presence of HBe antibody in glomerular deposits in membranous glomerulonephritis is associated with hepatitis B virus infection. Am J Nephrol 1988; 8: 384-7.
5. Lin CY. Hepatitis B virus deoxyribonucleic acid in kidney cells probably leading to viral pathogenesis among hepatitis B virus associated membranous nephropathy patients. Nephron 1993; 63: 58-64.
6. Lai KN, Ho RTH, Tam JS, Lai FMM. Detection of hepatitis B virus DNA and RNA in kidneys of HBV-related glomerulonephritis. Kidney Int 1996; 50: 1965-77.
7. Ohba S, Kimura K, Mise M et al. Differential localization of s and e antigens in hepatitis B virus-associated glomerulonephritis. Clin Nephrol 1997; 48: 44-7.
8. Lin CY, Lin CC, Chang GJJ, King CC. Defect of cell-mediated immune response against hepatitis B virus: an indication for pathogenesis of hepatitis B virus associated membranous nephropathy. Nephron 1997; 76: 176-85.
9. Xe YH, Fang LJ, Zhang YE, Sheng FY, Zhang XR, Guo MY. In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr Nephrol 1998; 12: 117-20.
10. Wang NS, Wu ZL, Zhang YE, Guo MY, Liao LT. Role of hepatitis B virus infection in pathogenesis of IgA nephropathy. World J Gastroenterol 2003; 9: 2004-8.
11. Lai KN, Tam JS, Lin HJ, Lai FMM. The therapeutic dilemma of the usage of corticosteroids in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990; 54: 12-7.
12. Ozdamar SO, Gucer S, Tinaztepe K. Hepatitis B virus associated nephropathies: a clinicopathological study in 14 children. Ped Nephrol 2003; 18: 23-8.
13. Takaki A, Nakatsuka A, Satou C, Iwata Y, Ikeda H, Fukushima M. A case of focal segmental glomerulosclerosis (FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis. Nippon Jinzo Gakkai Shi 2002; 44: 806-12.
14. Lin CL, Lo S. Treatment of hepatitis B virus-associated membranous nephropathy with adenine arabinoside and thymic extract. Kidney Int 1991; 39: 301-6.
15. De Man RA, Schalm SW, van der Heijden AJ, ten Kate FWJ, Wolff ED, Heijtink RA. Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy. J Hepatol 1989; 8: 367-72.
16. Poynard T, Conn HO. The retrieval of randomised clinical trials in liver diseases from the medical literature: a comparison of MEDLARS and manual methods. Control Clin Trials 1985; 6: 271-9.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-8.
18. Petitti DB. Approaches to heterogeneity in meta-analysis. Statist Med 2001; 20: 3625-33.
19. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Statist Med 2002; 21: 1559-73.
20. Begg CB, Mazumadar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-98.
21. Egger M, Smith DG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-34.
22. Lai KN, Li PKT, Lui SF et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991; 324: 1457-63.
23. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 1995; 47: 225-30.
24. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 1995; 109: 540-6.
25. Chung DR, Yang WS, Kim SB et al. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 1997; 17: 112-7.
26. Bhimma R, Coovadia HM, Kramvis A, Adhikari M, Kew MC. Treatment of hepatitis B virus-associated nephropathy in black children. Pediatr Nephrol 2002; 17: 393-9.
27. Tang S, Mac-Moune Lai F, Lui YH et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 2005; 68: 1750-8.
28. Lisker-Melman M, Webb D, Di Bisceglie A et al. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. Ann Int Med 1989; 111: 479-83.
29. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119: 312-23.
30. Di Bisceglie AM. Long-term outcome of interferon-alpha therapy for chronic hepatitis B. J Hepatol 1995; 22: S65-7.
31. Lin CY. Hepatitis B virus-associated membranous nephropathy: clinical features, immunologic profiles, and outcome. Nephron 1990; 55: 37-44.
32. Lai KN, Lai FMM. Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int 1991; 35: S40-5.
33. Pena A, Debora MJM, Melgosa M, Picazo ML, Navarro M. Membranous nephropathy associated with hepatitis B in Spanish children. Clin Nephrol 2001; 55: 25-30.
34. Knecht GL, Chisari FV. Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen. Gastroenterology 1978; 75: 1152-6.
35. Abbas NA, Pitt MA, Green AT, Solomon LR. Successful treatment of hepatitis B virus associated membranoproliferative glomerulonephritis with alpha interferon. Nephrol Dial Transplant 1999; 14: 1272-5.
36. Dhiman RK, Kohli HS, Das G, Joshi K, Chawla Y, Sakhuja V. Remission of HBV-related mesangioproliferative glomerulonephritis after interferon therapy. Nephrol Dial Transplant 1999; 14: 176-8.
37. Connor FL, Rosenberg AR, Kennedy SE, Bohane TD. HBV associated nephrotic syndrome: resolution with oral lamivudine. Arch Dis Child 2003; 88: 446-9.
38. Filler G, Feber J, Weiler G, Le Saux N. Another case of HBV associated membranous glomerulonephritis resolving on lamivudine. Arch Dis Child 2003; 88: 460 [letter].
39. Kanaan N, Horsmans Y, Goffin E. Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection. Clin Nephrol 2006; 65: 208-10.
40. Okuse C, Yotsuyanagi H, Yamada N et al. Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine. Clin Nephrol 2006; 65: 53-6.
41. Quan A, Portale A, Foster S, Lavine J. Resolution of hepatitis B virus-related membranoproliferative glomerulonephritis after orthotopic liver transplantation. Pediatr Nephrol 1995; 9: 599-602.
42. Bhimma R, Coovadia HM, Adhikari M, Connolly CA. The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy. Arch Pediatr Med 2003; 157: 1025-30.
43. Xu H, Sun L, Zhou LJ, Fang LJ, Sheng FY, Guo YQ. The effect of hepatitis B vaccination on the incidence of childhood HBV-associated nephritis. Pediatr Nephrol 2003; 18: 1216-9.